Omnicell has taken over a provider of analytical software for medication diversion detection and regulatory compliance, Pandora Data Systems.
Subscribe to our email newsletter
Following the acquisition, both the companies are expected to combine their expertise in medication analytics to enhance diversion detection and clinical benchmarking that helps to ensure regulatory compliance.
The Pandora Data Systems solution will continue to operate as a stand-alone product, producing reports for CareFusion, McKesson, Cerner and other medication management systems, and providing regular updates and releases for its customer base.
Pandora Data Systems CEO Jim Felich said that their partnership with the Omnicell team will allow to continue their commitment to patient safety and help hospital systems meet the increasingly stringent requirements of the DEA and The Joint Commission.
Omnicell CEO Randall Lipps said that Pandora’s analytic expertise will allow to further enhance hospital medication management, providing valuable information to pharmacy and nursing management while reducing the frequency of drug diversions.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.